🇺🇸 Heparin SC in United States

8 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 8

Most-reported reactions

1. Application Site Pruritus — 1 report (12.5%)
2. Cardio-Respiratory Arrest — 1 report (12.5%)
3. Cerebellar Haemorrhage — 1 report (12.5%)
4. Cough — 1 report (12.5%)
5. Hepatic Enzyme Increased — 1 report (12.5%)
6. Injection Site Pain — 1 report (12.5%)
7. Intraventricular Haemorrhage — 1 report (12.5%)
8. Liver Function Test Increased — 1 report (12.5%)

Source database →

Frequently asked questions

Is Heparin SC approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Heparin SC in United States?

Columbia University is the originator. The local marketing authorisation holder may differ — check the official source linked above.